Successful retreatment of HCV relapse patient with 4 weeks long sofsobuvir, ribavirin, and daclatasvir combination: Case Series

Hepatitis-C virus (HCV) is an enveloped RNA virus that currently infects more than 180 million people, worldwide. Interferon therapy was previously used as a standard therapy for HCV. Now it has been replaced with an interferon-free therapy or the direct acting antiviral (DAA) drug therapy. Althoug...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Komal Saleem, Amjad Ali, Shazia Rafique, Noshaba Rani, Braira Wahid
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	University of Management and Technology 2020-09-01
Цуврал:	Bioscientific Review
Нөхцлүүд:	genotype HCV HCV relapse non-responders therapy
Онлайн хандалт:	https://journals.umt.edu.pk/index.php/BSR/article/view/1119
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!